Net profit of Kilitch Drugs (India) rose 22.78% to Rs 2.91 crore in the quarter ended December 2023 as against Rs 2.37 crore during the previous quarter ended December 2022. Sales rose 6.07% to Rs 31.79 crore in the quarter ended December 2023 as against Rs 29.97 crore during the previous quarter ended December 2022.
Particulars | Quarter Ended |
| Dec. 2023 | Dec. 2022 | % Var. |
Sales | 31.79 | 29.97 | 6 |
OPM % | 7.17 | 13.28 | - |
PBDT | 3.64 | 3.38 | 8 |
PBT | 2.82 | 2.45 | 15 |
NP | 2.91 | 2.37 | 23 |